Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news


By Karen Loudon / January 21, 2019
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and...
Read More

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

By Karen Loudon / December 20, 2018 In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells...
Read More

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

By Karen Loudon / December 19, 2018
Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am A revolutionary cancer therapy that supercharges a patient's...
Read More